Skip to main content
Heron Neutron Medical Corp. (TPE:7799)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
471.00
-20.00 (-4.07%)
At close: Mar 6, 2026

Heron Neutron Medical Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22
Revenue
5.53-0.24-
Cost of Revenue
26.53.590.11-
Gross Profit
-20.97-3.590.13-
Selling, General & Admin
164.7782.0244.7936.23
Research & Development
295.33173.3984.8551.57
Operating Expenses
460.1255.41129.6487.8
Operating Income
-481.07-259-129.51-87.8
Interest Expense
-0.14-0.18-0.24-0.28
Interest & Investment Income
9.625.722.120.1
Currency Exchange Gain (Loss)
1.210.43-0.190.48
Other Non Operating Income (Expenses)
-0.22-0.94-
EBT Excluding Unusual Items
-470.61-253.03-126.88-87.49
Gain (Loss) on Sale of Investments
--0.491.31
Gain (Loss) on Sale of Assets
--7.05--
Pretax Income
-470.61-260.08-126.39-86.18
Net Income
-470.61-260.08-126.39-86.18
Net Income to Common
-470.61-260.08-126.39-86.18
Shares Outstanding (Basic)
14112810776
Shares Outstanding (Diluted)
14112810776
Shares Change (YoY)
16.38%19.11%40.45%-
EPS (Basic)
-3.34-2.04-1.18-1.13
EPS (Diluted)
-3.34-2.04-1.18-1.13
Free Cash Flow
-465.37-302.19-110.76-173.14
Free Cash Flow Per Share
-3.30-2.37-1.03-2.27
Gross Margin
--54.20%-
Operating Margin
-8705.52%--54415.97%-
Profit Margin
-8516.20%--53105.04%-
Free Cash Flow Margin
-8421.48%--46536.13%-
EBITDA
-457.81-242.89-119.36-78.91
D&A For EBITDA
23.2516.1110.158.89
EBIT
-481.07-259-129.51-87.8
Advertising Expenses
-3.24--
Source: S&P Capital IQ. Standard template. Financial Sources.